110 results
8-K
EX-99.1
acou8p9x7zsll60x
14 Dec 23
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
7:05am
8-K
EX-99.1
ww3u3cosi es
2 Nov 23
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
7:05am
8-K
EX-99.1
i0nbs8n18qx6y5
11 Sep 23
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
7:05am
8-K
EX-99.1
ykn8xh66 wdwdfexf0
3 Aug 23
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:59am
424B5
xqhd5udzly
13 Jul 23
Prospectus supplement for primary offering
4:17pm
424B5
tjygpf4so60zyye9z731
12 Jul 23
Prospectus supplement for primary offering
12:00am
424B5
af1vw irvsym3hrezl
26 May 23
Prospectus supplement for primary offering
5:25pm
S-3ASR
8z2yrg
26 May 23
Automatic shelf registration
4:53pm
8-K
u0fkurk
10 May 23
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
7:06am
8-K
EX-99.1
bh7ih65z b6
10 May 23
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
7:06am